Guided Versus Non-guided Pelvic Floor Exercises for Urinary Incontinence in Relapsing-Remitting Multiple Sclerosis

Assessment of the Effectiveness of Guided by a Physiotherapist Versus Non-guided Pelvic Floor Exercises for Urinary Incontinence (UI) in Patients With Relapsing-Remitting (RR) Multiple Sclerosis

The aim of the study is to evaluate the effectiveness of guided versus non guided pelvic floor exercises for urinary incontinence in patients with Relapsing-Remitting Multiple Sclerosis

Study Overview

Detailed Description

Subjects of the study should conduct a specific training in pelvic floor exercises. They were randomly assigned into 2 groups: Group A only received written instructions for exercises to be performed at home; Group B received written instructions and, in addition, exercises were performed in a 30 minutes weekly session with a physiotherapist guiding them

Study Type

Interventional

Enrollment (Actual)

48

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Madrid
      • Villalba, Madrid, Spain, 28400
        • Hospital General de Villalba

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Diagnosed with Relapsing-Remitting Multiple Sclerosis
  2. Diagnosed with Urinary Incontinence
  3. Minimental Sate Examination (MMSE) scale: More than 24
  4. Expanded Disability Status Scale (EDSS) scale: Bladder function 0-4; EDSS 0-6,5
  5. Willing to participate in the study
  6. Having Signed an informed consent

Exclusion Criteria:

  1. Diagnosed with another neurological disease
  2. Diagnosed with kidney diseases
  3. Having a Relapse of the disease in the last 6 months
  4. In Women: Pregnancy os postpartum < 6 months
  5. Having gone through surgery for urinary incontinence or prolapses or prostate diseases
  6. Having gone through other treatment for pelvic floor
  7. MMSE scale: Under 24
  8. EDSS scale: Bladder function 5-6 or not knowing; EDSS 7-10
  9. ICIQ-SF scale: Severity 19-21
  10. Not willing to participate or sign the informed consent form or not able to understand the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Guided Pelvic floor exercises
Pelvic floor exercises guided by a physiotherapist
Subjects perform two types of contractions of the pelvic floor in two different positions 3 times a day and once a week they check it with a physiotherapist (this day only they do it twice at home)
ACTIVE_COMPARATOR: Non-guided pelvic floor exercises
Pelvic floor exercises not guided
Subjects perform two types of contractions of the pelvic floor in two different positions 3 times a day. They do not attend to meetings with a physiotherapist

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Decrease in the number of urinary leakages from baseline
Time Frame: 12 weeks
Difference in the mean number of leakages (Registered for 3 days with a bladder diary)
12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Decrease of urinary incontinence severity from baseline
Time Frame: 4,8 and 12 weeks
Comparison of the results: Questions 1, 2 and 3 of the International Consultation on Incontinence Questionnaire (ICIQ-SF) between the group 1 and 2
4,8 and 12 weeks
Change in quality of life from baseline
Time Frame: 4,8 and 12 weeks
Comparison of the results (Question 3 of the questionnaire ICIQ-SF and second part (13 questions) of the Overactive Bladder questionnaire (OABQ-SF) between the group 1 and 2
4,8 and 12 weeks
Decrease in the number of urinary leakages from baseline
Time Frame: 4 and 8 weeks
Comparison of the results (Registered for 3 days with a bladder diary) between the group 1 and 2
4 and 8 weeks
Lower urinary tract symptoms from baseline
Time Frame: 4,8 and 12 weeks
Comparison of de results (First part (6 questions) of the questionnaire OABQ-SF) between the group 1 and 2
4,8 and 12 weeks
Adherence
Time Frame: 12 weeks
Comparison of the results (Registered with exercise diary)between the group 1 and 2
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Denise Cuevas, BSc, Universidad Rey Juan Carlos

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2015

Primary Completion (ACTUAL)

October 1, 2016

Study Completion (ACTUAL)

October 1, 2016

Study Registration Dates

First Submitted

December 14, 2016

First Submitted That Met QC Criteria

December 19, 2016

First Posted (ESTIMATE)

December 22, 2016

Study Record Updates

Last Update Posted (ACTUAL)

July 11, 2019

Last Update Submitted That Met QC Criteria

July 9, 2019

Last Verified

March 1, 2018

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Urinary Incontinence

Clinical Trials on Pelvic floor exercises guided by a physiotherapist

Subscribe